Checkpoint Therapeutics, Inc. (CKPT) Insider Trading & SEC Filings
Last SEC filing
Checkpoint Therapeutics, Inc. (CKPT) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every CKPT SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Checkpoint Therapeutics, Inc. (CKPT)
Checkpoint Therapeutics, Inc. trades under the ticker CKPT. InsiderAlpha tracks 12 primary SEC Form 4 filings from 8 reporting insiders for CKPT since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001651407 |
Recent CKPT Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael S. Weiss | Director | J - Other acquisition / disposition | 187.0K | - | - | SEC | |
| Neil Herskowitz | Director | J - Other acquisition / disposition | 147.0K | - | - | SEC | |
| Michael S. Weiss | Director | A - Grant or award | 50.0K | $1.29 | $64K | SEC | |
| Michael S. Weiss | Director | A - Grant or award | 12.2K | $0.00 | - | SEC | |
| Neil Herskowitz | Director | A - Grant or award | 12.2K | $0.00 | - | SEC | |
| James F. Oliviero III | CEO, President and Director | G - Bona-fide gift | 900.0K | $0.00 | - | SEC | |
| James F. Oliviero III | CEO, President and Director | S - Open-market sale | 220.2K | $3.38 | $744K | SEC | |
| William Garrett Gray | Chief Financial Officer | S - Open-market sale | 268.4K | $4.01 | $1.08M | SEC | |
| James F. Oliviero III | CEO, President and Director | S - Open-market sale | 602.2K | $3.87 | $2.33M | SEC | |
| Lindsay A. Md Rosenwald | Director | A - Grant or award | 12.6K | $0.00 | - | SEC | |
| Michael S. Weiss | Director | A - Grant or award | 12.6K | $0.00 | - | SEC | |
| Neil Herskowitz | Director | A - Grant or award | 17.6K | $0.00 | - | SEC | |
| Christian Bechon | Director | A - Grant or award | 15.0K | $0.00 | - | SEC | |
| James F. Oliviero III | CEO, President and Director | A - Grant or award | 2.08M | $0.00 | - | SEC | |
| Barry M. Salzman | Director | A - Grant or award | 17.6K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Checkpoint Therapeutics, Inc. (CKPT). Updated in real time as new filings are submitted to the SEC.
Recent Insider Filings
- - Neil Herskowitz (Director)
- - Michael S. Weiss (Director)
- - William Garrett Gray (Chief Financial Officer)
- - James F. Oliviero III (CEO, President and Director)
- - Christian Bechon (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CKPT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CKPT Insider Trading - FAQ
- What is the latest insider trade for CKPT?
- Checkpoint Therapeutics, Inc. (CKPT) had 0 insider filings in the last 90 days, with the most recent on 2025-05-28. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CKPT stock?
- 0 insider purchases of CKPT were filed in the last 90 days.
- How many insiders are selling CKPT stock?
- 0 insider sales of CKPT were filed in the last 90 days.
- Where can I see CKPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CKPT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CLRB Cellectar Biosciences, Inc.
- $COCH Envoy Medical, Inc.
- $COGT Cogent Biosciences, Inc.
- $CRSP CRISPR Therapeutics AG
- $CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
- $CV CapsoVision, Inc
- $CVKD Cadrenal Therapeutics, Inc.
- $CVM CEL SCI CORP
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- PERRIGO Co plc (PRGO)
- BeOne Medicines Ltd. (ONC)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CKPT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.